RAFAEL HOLDINGS, INC. Number of Reportable Segments
RAFAEL HOLDINGS, INC. (RFL) reported Number of Reportable Segments of 200.00% for the 6-month period ending 2022-01-31, per its 10-Q filed 2022-03-17.
Discontinued › Notes › Segment Reporting
us-gaap:NumberOfReportableSegments · last filed 2022-03-17
- RAFAEL HOLDINGS, INC. number of reportable segments for the quarter ending 2021-10-31 was 200.00%.
- RAFAEL HOLDINGS, INC. number of reportable segments for fiscal 2021 was 200.00%.
pure
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month |
|---|---|---|---|---|
| 2022-01-31 | 200.00% 10-Q · filed 2022-03-17 | |||
| 2021-10-31 | 200.00% 10-Q/A · filed 2022-02-28 | |||
| 2021-07-31 | 200.00% 10-K · filed 2021-10-18 | |||
| 2021-04-30 | 200.00% 10-Q · filed 2021-06-14 | |||
| 2021-01-31 | 200.00% 10-Q · filed 2021-03-17 | |||
| 2020-07-31 | 200.00% 10-Q · filed 2020-12-15 | |||
| 2020-04-30 | 200.00% 10-Q · filed 2020-06-09 |
Segments
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month |
|---|---|---|---|---|
| 2020-01-31 | 2.00 Segments 10-Q · filed 2020-03-05 | |||
| 2019-10-31 | 2.00 Segments 10-Q · filed 2019-12-09 | |||
| 2019-07-31 | 2.00 Segments 10-K · filed 2019-10-04 | |||
| 2019-04-30 | 2.00 Segments 10-Q · filed 2019-06-05 | |||
| 2019-01-31 | 2.00 Segments 10-Q · filed 2019-03-12 | |||
| 2018-10-31 | 2.00 Segments 10-Q · filed 2018-12-10 | |||
| 2018-07-31 | 2.00 Segments 10-K · filed 2018-10-15 | |||
| 2018-04-30 | 2.00 Segments 10-Q · filed 2018-06-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |